The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer
Open accessAbstract
The prostate-specific membrane antigen (PSMA) has received increased consideration during the past few years as an excellent target for both imaging and therapy of prostate cancer. After many years of outstanding preclinical research, the first significant step forward in clinical use was achieved in 2008 with the first human experience with the small-molecule PSMA inhibitors 123I-MIP-1972 and 123I-MIP-1095. A clinical breakthrough followed in 2011 with 68Ga-PSMA-11 for PET imaging and 131I-MIP-1095 for endoradiotherapy of metastatic prostate cancer. Since then, PET/CT with 68Ga-PSMA-11 has rapidly spread worldwide, and endoradiotherapy with PSMA ligands has been conducted at increasing numbers of centers. 68Ga-PSMA-11 is currently the subject of multicenter studies in different countries. Since 2013, 131I-related PSMA therapy has been replaced by 177Lu-labeled ligands, such as PSMA-617, which is also the subject of multicenter studies. Alternative PSMA ligands for both imaging and therapy are available. Among them is 99mTc-MIP-1404, which has recently entered a phase 3 clinical trial. This article focuses on the highlights of the development and clinical application of PSMA ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eiber, M., Maurer, T., Souvatzoglou, M., Beer, A. J., Ruffani, A., Haller, B., Graner, F.-P., Kübler, H., Haberhorn, U., Eisenhut, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154153 · Cited by 994
Self-citationAfshar-Oromieh, A., Avtzi, E., Giesel, F. L., Holland-Letz, T., Linhart, H. G., Eder, M., Eisenhut, M., Boxler, S., Hadaschik, B. A., Kratochwil, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2949-6 · Cited by 964
Self-citationAfshar-Oromieh, A., Zechmann, C. M., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Holland-Letz, T., Hadaschik, B. A., Giesel, F. L., Debus, J., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2525-5 · Cited by 921
Self-citationAfshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
Self-citation68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
Self-citationMaurer, T., Gschwend, J. E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., Wester, H.-J., Heck, M., Kübler, H., Beer, A. J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.12.025 · Cited by 779
Kratochwil, C., Giesel, F. L., Stefanova, M., Benešová, M., Bronzel, M., Afshar-Oromieh, A., Mier, W., Eder, M., Kopka, K., & Haberkorn, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171397 · Cited by 636
Self-citationUpregulation of prostate-specific membrane antigen after androgen-deprivation therapy
Wright, G. L., Mayer Grob, B., Haley, C., Grossman, K., Newhall, K., Petrylak, D., Troyer, J., Konchuba, A., Schellhammer, P. F., & Moriarty, R. (1996) · Urology · doi:10.1016/s0090-4295(96)00184-7 · Cited by 635
Benešová, M., Schäfer, M., Bauder-Wüst, U., Afshar-Oromieh, A., Kratochwil, C., Mier, W., Haberkorn, U., Kopka, K., & Eder, M. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147413 · Cited by 612
Self-citationSweat, S. D., Pacelli, A., Murphy, G. P., & Bostwick, D. G. (1998) · Urology · doi:10.1016/s0090-4295(98)00278-7 · Cited by 607
Expression of the prostate-specific membrane antigen.
Israeli, R., Powell, C. T., Corr, J., Fair, W. R., & Heston, W. D. W. (1994) · PubMed · Cited by 601
Morigi, J. J., Stricker, P. D., van Leeuwen, P. J., Tang, R., Ho, B., Nguyen, Q., Hruby, G., Fogarty, G., Jagavkar, R., Kneebone, A., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160382 · Cited by 571
Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
Eiber, M., Weirich, G., Holzapfel, K., Souvatzoglou, M., Haller, B., Rauscher, I., Beer, A. J., Wester, H.-J., Gschwend, J., Schwaiger, M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.053 · Cited by 568
Baum, R. P., Kulkarni, H. R., Schuchardt, C., Singh, A., Wirtz, M., Wiessalla, S., Schottelius, M., Mueller, D., Klette, I., & Wester, H.-J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168443 · Cited by 525
Bander, N. H., Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Vallabhajosula, S., & Goldsmith, S. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.160 · Cited by 509
Szabo, Z., Mena, E., Rowe, S. P., Plyku, D., Nidal, R., Eisenberger, M. A., Antonarakis, E. S., Fan, H., Dannals, R. F., Chen, Y., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0850-8 · Cited by 443
Afshar-Oromieh, A., Hetzheim, H., Kratochwil, C., Benesova, M., Eder, M., Neels, O. C., Eisenhut, M., Kübler, W., Holland-Letz, T., Giesel, F. L., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161299 · Cited by 427
Self-citationChen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
(1993) · Biotechnology Advances · doi:10.1016/0734-9750(93)90273-p · Cited by 378
Carter, R. E., Feldman, A. R., & Coyle, J. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.749 · Cited by 372
Eder, M., Neels, O., Müller, M., Bauder-Wüst, U., Remde, Y., Schäfer, M., Hennrich, U., Eisenhut, M., Afshar-Oromieh, A., Haberkorn, U., et al. (2014) · Pharmaceuticals · doi:10.3390/ph7070779 · Cited by 370
Self-citationZechmann, C. M., Afshar-Oromieh, A., Armor, T., Stubbs, J. B., Mier, W., Hadaschik, B., Joyal, J., Kopka, K., Debus, J., Babich, J. W., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2713-y · Cited by 358
Self-citationAfshar-Oromieh, A., Haberkorn, U., Eder, M., Eisenhut, M., & Zechmann, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2069-0 · Cited by 325
Self-citationAfshar-Oromieh, A., Haberkorn, U., Schlemmer, H. P., Fenchel, M., Eder, M., Eisenhut, M., Hadaschik, B. A., Kopp-Schneider, A., & Röthke, M. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2660-z · Cited by 325
Self-citationDelker, A., Fendler, W. P., Kratochwil, C., Brunegraf, A., Gosewisch, A., Gildehaus, F. J., Tritschler, S., Stief, C. G., Kopka, K., Haberkorn, U., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3174-7 · Cited by 322
Self-citationEvans, M. J., Smith-Jones, P. M., Wongvipat, J., Navarro, V., Kim, S., Bander, N. H., Larson, S. M., & Sawyers, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106383108 · Cited by 316
Hillier, S. M., Maresca, K. P., Femia, F. J., Marquis, J. C., Foss, C. A., Nguyen, N., Zimmerman, C. N., Barrett, J. A., Eckelman, W. C., Pomper, M. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1682 · Cited by 316
Self-citationTHE RELATIVE IMPACT AND FUTURE BURDEN OF PROSTATE CANCER IN THE UNITED STATES
CHAN, J. M., JOU, R. M., & CARROLL, P. R. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142068.66876.53 · Cited by 303
Maresca, K. P., Hillier, S. M., Femia, F. J., Keith, D., Barone, C., Joyal, J. L., Zimmerman, C. N., Kozikowski, A. P., Barrett, J. A., Eckelman, W. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800994j · Cited by 295
Self-citationHerlemann, A., Wenter, V., Kretschmer, A., Thierfelder, K. M., Bartenstein, P., Faber, C., Gildehaus, F.-J., Stief, C. G., Gratzke, C., & Fendler, W. P. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.051 · Cited by 295
Ahmadzadehfar, H., Eppard, E., Kürpig, S., Fimmers, R., Yordanova, A., Schlenkhoff, C. D., Gärtner, F., Rogenhofer, S., & Essler, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7245 · Cited by 282
Ceci, F., Uprimny, C., Nilica, B., Geraldo, L., Kendler, D., Kroiss, A., Bektic, J., Horninger, W., Lukas, P., Decristoforo, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3078-6 · Cited by 262
Jackson, P. F., Cole, D. C., Slusher, B. S., Stetz, S. L., Ross, L. E., Donzanti, B. A., & Trainor, D. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950801q · Cited by 256
Hillier, S. M., Maresca, K. P., Lu, G., Merkin, R. D., Marquis, J. C., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116624 · Cited by 230
Self-citation68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Banerjee, S. R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Green, G., Fox, J. J., Horti, A., Mease, R. C., & Pomper, M. G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100623e · Cited by 213
Kabasakal, L., AbuQbeitah, M., Aygün, A., Yeyin, N., Ocak, M., Demirci, E., & Toklu, T. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3125-3 · Cited by 208
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
Barrett, J. A., Coleman, R. E., Goldsmith, S. J., Vallabhajosula, S., Petry, N. A., Cho, S., Armor, T., Stubbs, J. B., Maresca, K. P., Stabin, M. G., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111203 · Cited by 208
Self-citation[177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer
Kratochwil, C., Giesel, F. L., Eder, M., Afshar-Oromieh, A., Benešová, M., Mier, W., Kopka, K., & Haberkorn, U. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2978-1 · Cited by 196
Self-citationRadiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Afshar-Oromieh, A., Hetzheim, H., Kübler, W., Kratochwil, C., Giesel, F. L., Hope, T. A., Eder, M., Eisenhut, M., Kopka, K., & Haberkorn, U. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3419-0 · Cited by 185
Self-citationKrohn, T., Verburg, F. A., Pufe, T., Neuhuber, W., Vogg, A., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2915-3 · Cited by 180
Freitag, M. T., Radtke, J. P., Hadaschik, B. A., Kopp-Schneider, A., Eder, M., Kopka, K., Haberkorn, U., Roethke, M., Schlemmer, H.-P., & Afshar-Oromieh, A. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3206-3 · Cited by 165
Self-citationPSMA as a target for radiolabelled small molecules
Eder, M., Eisenhut, M., Babich, J. W., & Haberkorn, U. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2374-2 · Cited by 149
Self-citationHerrmann, K., Bluemel, C., Weineisen, M., Schottelius, M., Wester, H., Czernin, J. G., Eberlein, U., Beykan, S., Lapa, C., Riedmiller, H. N., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156133 · Cited by 148
Baek, S. E., Lee, K. H., Park, Y. S., Oh, D., Oh, S., Kim, K., & Kim, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.018 · Cited by 148
Vallabhajosula, S., Nikolopoulou, A., Babich, J. W., Osborne, J. R., Tagawa, S. T., Lipai, I., Sólnes, L. B., Maresca, K. P., Armor, T., Joyal, J. L., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.140426 · Cited by 145
Self-citationPomper, M. G., Musachio, J. L., Zhang, J., Scheffel, U., Zhou, Y., Hilton, J., Maini, A., Dannals, R. F., Wong, D. F., & Kozikowski, A. P. (2002) · Molecular Imaging · doi:10.1162/153535002320162750 · Cited by 138
Vallabhajosula, S., Kuji, I., Hamacher, K. A., Konishi, S., Kostakoğlu, L., Kothari, P. A., Milowsky, M. I., Nanus, D. M., Bander, N. H., & Goldsmith, S. J. (2005) · PubMed · Cited by 130
Marchal, C., Redondo, M., Padilla, M., Caballero, J., Rodrigo, I., Garcia, J., Quian, J., & Boswick, D. G. (2004) · PubMed · doi:10.14670/hh-19.715 · Cited by 129
64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
Banerjee, S. R., Pullambhatla, M., Foss, C. A., Nimmagadda, S., Ferdani, R., Anderson, C. J., Mease, R. C., & Pomper, M. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401921j · Cited by 122
Giesel, F. L., Fiedler, H., Stefanova, M., Sterzing, F., Rius, M., Kopka, K., Moltz, J. H., Afshar‐Oromieh, A., Choyke, P. L., Haberkorn, U., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3106-6 · Cited by 120
Self-citationGiesel, F. L., Sterzing, F., Schlemmer, H., Holland‐Letz, T., Mier, W., Rius, M., Afshar‐Oromieh, A., Kopka, K., Debus, J., Haberkorn, U., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3346-0 · Cited by 113
Self-citationGrauer, L. S., Lawler, K. D., Marignac, J. L., Kumar, A., Goel, A. S., & Wolfert, R. L. (1998) · PubMed · Cited by 98
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
Rosenthal, S. A., Haseman, M. K., & Polascik, T. J. (2001) · PubMed · Cited by 91
Lu, G., Maresca, K. P., Hillier, S., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.014 · Cited by 89
Self-citationMolecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).
Luthi‐Carter, R., Barczak, A. K., Speno, H. S., & Coyle, J. T. (1998) · PubMed · Cited by 88
Hohberg, M., Eschner, W., Schmidt, M. C., Dietlein, M., Kobe, C., Fischer, T. H., Drzezga, A. E., & Wild, M. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0942-0 · Cited by 85
Hillier, S., Kern, A. M., Maresca, K. P., Marquis, J. C., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086751 · Cited by 84
Self-citationOsborne, J. R., Green, D. A., Spratt, D. E., Lyashchenko, S. K., Fareedy, S. B., Robinson, B. D., Beattie, B. J., Jain, M., Lewis, J. S., Christos, P. J., et al. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.10.041 · Cited by 80
Schuster, D. M., Taleghani, P. A., Nieh, P. T., Master, V. A., Amzat, R., Savir-Baruch, B., HALKAR, R. K., Fox, T. H., Osunkoya, A. O., Moreno, C. S., et al. (2013) · PubMed · Cited by 79
Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Jackson, P., & Slusher, B. S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372797 · Cited by 75
WILKINSON, S., & Chodak, G. W. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000132138.02846.08 · Cited by 73
Vallabhajosula, S., Smith-Jones, P. M., Navarro, V., Goldsmith, S. J., & Bander, N. H. (2003) · The Prostate · doi:10.1002/pros.10281 · Cited by 65
Liu, T., Wu, L. Y., Fulton, M. D., JOHNSON, J. M., & Berkman, C. E. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1649 · Cited by 63
Cachin, F., Miot-Noirault, E., Gillet, B., Isnardi, V., Labeille, B., Payoux, P., Meyer, N., Cammilleri, S., Gaudy‐Marqueste, C., Razzouk‐Cadet, M., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123554 · Cited by 58
New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.
Maffioli, L. S., Florimonte, L., Costa, D. C., Castanheira, J. C., Grana, C. M., Luster, M., Bodei, L., & Chinol, M. (2015) · PubMed · Cited by 26
Tagawa, S. T., Akhtar, N. H., Christos, P. J., Osborne, J. R., Vallabhajosula, S., Freedy, S., Goldsmith, S. J., Nanus, D. M., & Bander, N. H. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.11081 · Cited by 3
Cited by
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095023 · Cited by 337
Sheikhbahaei, S., Afshar-Oromieh, A., Eiber, M., Solnes, L. B., Javadi, M. S., Ross, A. E., Pienta, K. J., Allaf, M. E., Haberkorn, U., Pomper, M. G., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3780-7 · Cited by 295
Self-citation
Metadata
- Authors
- Afshar-Oromieh, A., Babich, J. W., Kratochwil, C., Giesel, F. L., Eisenhut, M., Kopka, K., & Haberkorn, U.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2016-10
- Volume
- 57
- Issue
- Supplement 3
- Pages
- 79S-89S
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2525349940
- Cited by
- 257
- References
- 66
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.